Why the study?
Managing T2DM in geriatric patients is challenging due to age-related changes, polypharmacy, and adverse drug reactions, prompting an assessment of antidiabetic prescribing patterns in elderly patients with T2DM and hypertension.
Answers are grounded in this paper and cite their sources.
Metformin and sulfonylureas remain the mainstay of type 2 diabetes treatment in elderly hypertensive patients in India, characterized by a high prevalence of rational generic prescribing and combination therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Narayanappa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: